CCNG2 and chronic myelogenous leukemia, BCR-ABL1 positive: Furthermore, BMI-1 and CCNG2 levels evolved inversely during CML progression, suggesting that BMI-1 could support acute transformation of CML through the silencing of a CCNG2-mediated tumor-suppressive autophagy response.